Adagene
ADAG
16 hedge funds and large institutions have $67.3M invested in Adagene in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 5 closing their positions.
0.76% less ownership
Funds ownership: 16.15% → 15.39% (-0.76%)
16% less funds holding
Funds holding: 19 → 16 (-3)
47% less capital invested
Capital invested by funds: $127M → $67.3M (-$59.3M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$172K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$13.1K |
| 3 |
Morgan Stanley
New York
|
+$12.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
CloudAlpha Capital Management
Hong Kong
|
-$4.31M |
| 2 |
SCM
Suvretta Capital Management
New York
|
-$614K |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
-$463K |
| 4 |
SVI
Strategic Vision Investment
Hong Kong
|
-$340K |
| 5 |
O
OrbiMed
New York
|
-$121K |
ADAG Hedge Fund Activity: Q4 2021 in Review
16 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Adagene (ADAG) for Q4 2021, worth a combined $67.3M — down 47% from $127M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ADAG and 2 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 1 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $172K. The largest seller was CloudAlpha Capital Management, exiting entirely with an estimated $4.31M sold.
- 16 institutional investors held Adagene (ADAG) as of Q4 2021, down from 19 in Q3 2021.
- Funds reported $67.3M of Adagene stock for Q4 2021, down 47% quarter-over-quarter.
- 2 funds opened new Adagene positions in Q4 2021 and 5 closed out, a net change of -3 holders.
- The largest Adagene buyer in Q4 2021 was Citadel Advisors, an estimated $172K added.
- The largest Adagene seller in Q4 2021 was CloudAlpha Capital Management, an estimated $4.31M sold.
Based on aggregated 13F filings for Q4 2021.